Department of gynaecology and obstetrics, the Affiliated Zhuzhou Hospital Xiangya Medical College, Central South University, 412000, Zhuzhou, Hunan, China.
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, 410008, Changsha, Hunan, China.
J Ovarian Res. 2023 Mar 1;16(1):47. doi: 10.1186/s13048-023-01120-6.
Curcumin, a natural organic component obtained from Curcuma longa's rhizomes, shows abundant anti-tumor, antioxidant and anti-inflammatory pharmacological activities, among others. Notably the anti-tumor activity has aroused widespread attention from scholars worldwide. Numerous studies have reported that curcumin can delay ovarian cancer (OC), increase its sensitivity to chemotherapy, and reduce chemotherapy drugs' side effects. It has been shown considerable anticancer potential by promoting cell apoptosis, suppressing cell cycle progression, inducing autophagy, inhibiting tumor metastasis, and regulating enzyme activity. With an in-depth study of curcumin's anti-OC mechanism, its clinical application will have broader prospects. This review summarizes the latest studies on curcumin's anti-OC activities, and discusses the specific mechanism, hoping to provide references for further research and applications.
姜黄素是从姜黄根茎中提取的一种天然有机成分,具有丰富的抗肿瘤、抗氧化和抗炎药理活性等。特别是抗肿瘤活性引起了全球学者的广泛关注。大量研究表明,姜黄素可以延缓卵巢癌(OC)的发展,增加其对化疗的敏感性,并降低化疗药物的副作用。它通过促进细胞凋亡、抑制细胞周期进程、诱导自噬、抑制肿瘤转移和调节酶活性显示出相当大的抗癌潜力。随着对姜黄素抗 OC 机制的深入研究,其临床应用将具有更广阔的前景。本综述总结了姜黄素抗 OC 活性的最新研究,并讨论了具体的机制,希望为进一步的研究和应用提供参考。